Phenethyl Isothiocyanate

Phenethyl isothiocyanate (PEITC) is a naturally occurring isothiocyanate derived from the hydrolysis of gluconasturtiin, a glucosinolate found in cruciferous vegetables such as watercress and garden cress. It exerts chemopreventive effects primarily by modulating phase I and phase II detoxification enzymes, inducing apoptosis, and arresting the cell cycle at G2/M phase in cancer cell lines.

Category: Compound Evidence: 2/10 Tier: Emerging
Phenethyl Isothiocyanate — Hermetica Encyclopedia

Origin & History

Phenethyl isothiocyanate (PEITC) is a naturally occurring organosulfur compound (C₉H₉NS) found in cruciferous vegetables, particularly horseradish, radish, and watercress. It is produced when the enzyme myrosinase hydrolyzes its precursor glucosinolate (gluconasturtiin) upon plant tissue damage, yielding a colorless to pale yellow liquid.

Historical & Cultural Context

No historical or traditional medicine uses were documented in the available research for PEITC specifically. While cruciferous vegetables containing PEITC have been consumed for centuries, isolated compound use lacks documented traditional applications.

Health Benefits

• Potential cancer prevention through cell cycle arrest and apoptosis induction (preliminary evidence from in vitro studies)
• May reduce oxidation of carcinogen NNK and boost detoxification enzymes (animal/cell studies only)
• Possible anti-angiogenic effects by inhibiting VEGF secretion in glioma cells (in vitro evidence)
• Potential to disrupt cancer cell mitochondrial function through Bcl-xl/Bax modulation (cell culture studies)
• May inhibit PI3K/MAPK signaling pathways in cancer cells (preliminary laboratory evidence)

How It Works

PEITC inhibits cytochrome P450 enzymes, particularly CYP2E1 and CYP2A6, reducing the metabolic activation of carcinogens such as the tobacco-specific nitrosamine NNK, while simultaneously inducing phase II enzymes including glutathione S-transferase and NAD(P)H quinone oxidoreductase 1 (NQO1) via Nrf2/ARE pathway activation. At the cellular level, PEITC promotes apoptosis by activating caspase-3 and caspase-9, downregulating anti-apoptotic Bcl-2 and Bcl-xL proteins, and triggering mitochondrial cytochrome c release. Additionally, PEITC suppresses VEGF secretion in glioma cells by inhibiting HIF-1α accumulation, thereby reducing tumor angiogenesis.

Scientific Research

While DrugBank indicates PEITC has been used in trials for leukemia, lung cancer, and tobacco use disorder prevention, no specific human clinical trial details, sample sizes, or PMIDs were provided in the available research. The only cited reference (Clin. Cancer Res. 11, 2670, 2005) suggests chemopreventive investigation, but lacks accompanying clinical outcome data.

Clinical Summary

The majority of evidence supporting PEITC comes from in vitro cell culture studies and rodent models, with limited human clinical data available. Animal studies in A/J mice demonstrated that dietary PEITC at doses of 3–10 µmol/g diet significantly reduced NNK-induced lung tumorigenesis by up to 50%. A small pharmacokinetic study in humans consuming 85 g of watercress showed detectable PEITC metabolites in urine and measurable inhibition of CYP2E1 activity, but no randomized controlled trials have confirmed clinical cancer prevention outcomes in humans. Overall, the evidence remains preliminary and largely preclinical, and PEITC cannot currently be recommended as a standalone therapeutic agent.

Nutritional Profile

Phenethyl Isothiocyanate (PEITC) is a pure bioactive organosulfur compound, not a whole food, and therefore contains no macronutrients (zero protein, fat, or carbohydrates), no dietary fiber, and no vitamins or minerals in its isolated form. Its entire profile is defined by its single active molecule: PEITC (molecular formula C9H9NS, molecular weight 163.24 g/mol), a naturally occurring isothiocyanate derived from the glucosinolate gluconasturtiin via myrosinase hydrolysis. In food sources such as watercress, PEITC concentrations range approximately 20–60 mg per 100g fresh weight, with garden cress and nasturtium leaves containing up to 100 mg/100g. As an isolated compound, it is typically studied at concentrations of 5–20 micromolar (µM) in cell studies and 10–50 mg/kg body weight in animal models. Bioavailability is notably high compared to other isothiocyanates: oral absorption is estimated at 50–80% in humans, with peak plasma concentrations reached within 1–3 hours post-ingestion. PEITC undergoes rapid conjugation with glutathione in enterocytes, forming a dithiocarbamate conjugate that circulates systemically and is excreted primarily via urine as N-acetylcysteine conjugates (mercapturic acid pathway). Half-life in plasma is approximately 2–4 hours. No clinically meaningful concentrations of vitamins, minerals, or other micronutrients are associated with PEITC in its isolated compound form.

Preparation & Dosage

No clinically studied dosage ranges, standardized forms, or human therapeutic doses have been established based on the available research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other isothiocyanates, sulforaphane, indole-3-carbinol, vitamin C, selenium

Safety & Interactions

PEITC is generally considered safe when consumed through dietary sources such as watercress at typical food amounts, but concentrated supplemental doses have not been rigorously evaluated for long-term safety in humans. Because PEITC inhibits CYP2E1 and CYP2A6, it may alter the metabolism of drugs processed by these enzymes, including acetaminophen, chlorzoxazone, and nicotine-derived compounds, potentially raising or lowering their plasma concentrations. High-dose PEITC has shown hepatotoxic and nephrotoxic effects in rodent studies, raising concerns about supplemental use above physiological dietary levels. Pregnant and breastfeeding women should avoid supplemental PEITC due to insufficient safety data, though normal dietary intake from cruciferous vegetables is not considered a concern.